Cargando…

Stromal Cells Serve Drug Resistance for Multiple Myeloma via Mitochondrial Transfer: A Study on Primary Myeloma and Stromal Cells

SIMPLE SUMMARY: Mitochondrial transfer plays a crucial role in the acquisition of drug resistance in multiple myeloma, but its exact mechanism is not yet clear; moreover, overcoming the drug resistance that it causes is also a major challenge. Our research on primary myeloma cell cultures reveals th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matula, Zsolt, Mikala, Gábor, Lukácsi, Szilvia, Matkó, János, Kovács, Tamás, Monostori, Éva, Uher, Ferenc, Vályi-Nagy, István
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307863/ https://www.ncbi.nlm.nih.gov/pubmed/34298674 http://dx.doi.org/10.3390/cancers13143461

Ejemplares similares

The Effect of Belantamab Mafodotin on Primary Myeloma–Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells
por: Matula, Zsolt, et al.
Publicado: (2023)

Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes–A feasibility study
por: Marx, Anita, et al.
Publicado: (2023)

Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers
por: Szita, Virág Réka, et al.
Publicado: (2022)

Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy
por: Matula, Zsolt, et al.
Publicado: (2022)

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans
por: Vályi-Nagy, István, et al.
Publicado: (2021)

Identification of Galectin-1 as a Critical Factor in Function of Mouse Mesenchymal Stromal Cell-Mediated Tumor Promotion
por: Szebeni, Gábor János, et al.
Publicado: (2012)

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
por: Maiso, Patricia, et al.
Publicado: (2021)

Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency
por: Goda, Vera, et al.
Publicado: (2022)

Targeted drug combination therapy design based on driver genes
por: Zsákai, Lilian, et al.
Publicado: (2019)

Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells
por: Zdzisińska, Barbara, et al.
Publicado: (2008)

Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells
por: Espagnolle, Nicolas, et al.
Publicado: (2020)

Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma
por: Ria, Roberto, et al.
Publicado: (2020)

Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease
por: Garcia-Gomez, Antonio, et al.
Publicado: (2014)

The effect of marrow stromal cells on TRAF6 expression levels in myeloma cells
por: Huang, Hongming, et al.
Publicado: (2017)

Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?
por: Vályi-Nagy, István, et al.
Publicado: (2022)

Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells
por: André, Thibaud, et al.
Publicado: (2013)

Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes
por: Westhrin, Marita, et al.
Publicado: (2018)

Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma
por: Dun, Xiaoyi, et al.
Publicado: (2010)

Myeloma: A Lot of Progress, Still a Long Way to Go
por: Mikala, Gábor, et al.
Publicado: (2021)

Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
por: Markovina, Stephanie, et al.
Publicado: (2010)

Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity
por: Özcan, Servet, et al.
Publicado: (2015)

TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal Cells
por: Morgan, Jonathan J., et al.
Publicado: (2019)

The morphology and differentiation of stromal cells in the cortex of follicles in the bursa of Fabricius of the chicken
por: Oláh, Imre, et al.
Publicado: (2022)

Imprinting of Mesenchymal Stromal Cell Transcriptome Persists even after Treatment in Patients with Multiple Myeloma
por: Lemaitre, Léa, et al.
Publicado: (2020)

Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma
por: Choi, Hayoung, et al.
Publicado: (2020)

Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease
por: Garcia-Gomez, Antonio, et al.
Publicado: (2021)

Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells
por: Cippitelli, Marco, et al.
Publicado: (2023)

Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment
por: Urban, Veronika S., et al.
Publicado: (2022)

Beneficial Effect of Lenalidomide-Dexamethason Treatment in Relapsed/Refractory Multiple Myeloma Patients: Results of Real-Life Data From 11 Hungarian Centers
por: Varga, Gergely, et al.
Publicado: (2021)

B01: STROMAL CELL-NEUTROPHIL INTERACTIONS PROMOTE A PRO-TUMOR ENVIRONMENT IN MULTIPLE MYELOMA
por: de Jong, M, et al.
Publicado: (2022)

Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program
por: Varga, Gergely, et al.
Publicado: (2019)

The scaffold protein Tks4 is required for the differentiation of mesenchymal stromal cells (MSCs) into adipogenic and osteogenic lineages
por: Dülk, Metta, et al.
Publicado: (2016)

Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary
por: Lovas, Szilvia, et al.
Publicado: (2022)

Reelin promotes adhesion of multiple myeloma cells to bone marrow stromal cells via integrin β1 signaling
por: Lin, Liang, et al.
Publicado: (2017)

P828: EFFECT OF ANTI-CD38 MONOCLONAL ANTIBODIES ON THE INTERACTION OF MYELOMA CELLS WITH BONE MARROW STROMAL CELLS
por: Lienhart, Malgorzata, et al.
Publicado: (2023)

Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature
por: Varga, Gergely, et al.
Publicado: (2018)

HIF-2α-ILK Is Involved in Mesenchymal Stromal Cell Angiogenesis in Multiple Myeloma Under Hypoxic Conditions
por: Zhang, Xiaoying, et al.
Publicado: (2018)

TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma
por: Giallongo, Cesarina, et al.
Publicado: (2019)

Cx43 expressed on bone marrow stromal cells plays an essential role in multiple myeloma cell survival and drug resistance
por: Fu, Jinxiang
Publicado: (2016)

Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells
por: Lin, Xuanru, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uifk28im3kbl0mbs83jaq9qdbv